These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 36300343)
1. AKBA inhibits radiotherapy resistance in lung cancer by inhibiting maspin methylation and regulating the AKT/FOXO1/p21 axis. Gong C; Li W; Wu J; Li YY; Ma Y; Tang LW J Radiat Res; 2023 Jan; 64(1):33-43. PubMed ID: 36300343 [TBL] [Abstract][Full Text] [Related]
2. Acetyl-11-keto-β-boswellic acid enhances the cisplatin sensitivity of non-small cell lung cancer cells through cell cycle arrest, apoptosis induction, and autophagy suppression via p21-dependent signaling pathway. Lv M; Zhuang X; Zhang Q; Cheng Y; Wu D; Wang X; Qiao T Cell Biol Toxicol; 2021 Apr; 37(2):209-228. PubMed ID: 32562082 [TBL] [Abstract][Full Text] [Related]
3. Acetyl-11-keto-β-boswellic acid inhibits proliferation and induces apoptosis of gastric cancer cells through the phosphatase and tensin homolog /Akt/ cyclooxygenase-2 signaling pathway. Sun MX; He XP; Huang PY; Qi Q; Sun WH; Liu GS; Hua J World J Gastroenterol; 2020 Oct; 26(38):5822-5835. PubMed ID: 33132637 [TBL] [Abstract][Full Text] [Related]
4. 3-O-acetyl-11-keto-β-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2/M phase. Li W; Liu J; Fu W; Zheng X; Ren L; Liu S; Wang J; Ji T; Du G J Exp Clin Cancer Res; 2018 Jul; 37(1):132. PubMed ID: 29970196 [TBL] [Abstract][Full Text] [Related]
5. Acetyl-11-keto-β-boswellic acid suppresses docetaxel-resistant prostate cancer cells in vitro and in vivo by blocking Akt and Stat3 signaling, thus suppressing chemoresistant stem cell-like properties. Liu YQ; Wang SK; Xu QQ; Yuan HQ; Guo YX; Wang Q; Kong F; Lin ZM; Sun DQ; Wang RM; Lou HX Acta Pharmacol Sin; 2019 May; 40(5):689-698. PubMed ID: 30171201 [TBL] [Abstract][Full Text] [Related]
6. Acetyl-11-Keto-β-Boswellic Acid Exerts the Anti-Cancer Effects via Cell Cycle Arrest, Apoptosis Induction and Autophagy Suppression in Non-Small Cell Lung Cancer Cells. Lv M; Shao S; Zhang Q; Zhuang X; Qiao T Onco Targets Ther; 2020; 13():733-744. PubMed ID: 32158225 [TBL] [Abstract][Full Text] [Related]
7. Cinobufagin induces FOXO1-regulated apoptosis, proliferation, migration, and invasion by inhibiting G9a in non-small-cell lung cancer A549 cells. Zhang L; Liang B; Xu H; Gong Y; Hu W; Jin Z; Wu X; Chen X; Li M; Shi L; Shi Y; Wang Y; Yang L J Ethnopharmacol; 2022 Jun; 291():115095. PubMed ID: 35176466 [TBL] [Abstract][Full Text] [Related]
8. LY294002 enhances boswellic acid-induced apoptosis in colon cancer cells. Liu JJ; Duan RD Anticancer Res; 2009 Aug; 29(8):2987-91. PubMed ID: 19661305 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of microRNA-181a may suppress proliferation and invasion and promote apoptosis of cervical cancer cells through the PTEN/Akt/FOXO1 pathway. Xu H; Zhu J; Hu C; Song H; Li Y J Physiol Biochem; 2016 Dec; 72(4):721-732. PubMed ID: 27534652 [TBL] [Abstract][Full Text] [Related]
10. Acetyl-11-keto-β-boswellic acid (AKBA) inhibits human gastric carcinoma growth through modulation of the Wnt/β-catenin signaling pathway. Zhang YS; Xie JZ; Zhong JL; Li YY; Wang RQ; Qin YZ; Lou HX; Gao ZH; Qu XJ Biochim Biophys Acta; 2013 Jun; 1830(6):3604-15. PubMed ID: 23500016 [TBL] [Abstract][Full Text] [Related]
11. Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway. Zhao Z; Li C; Xi H; Gao Y; Xu D Mol Med Rep; 2015 Oct; 12(4):5415-22. PubMed ID: 26166196 [TBL] [Abstract][Full Text] [Related]
12. Acetyl-keto-beta-boswellic acid inhibits cellular proliferation through a p21-dependent pathway in colon cancer cells. Liu JJ; Huang B; Hooi SC Br J Pharmacol; 2006 Aug; 148(8):1099-107. PubMed ID: 16783403 [TBL] [Abstract][Full Text] [Related]
13. Boswellic acid sensitizes gastric cancer cells to Cisplatin-induced apoptosis via p53-mediated pathway. Al-Bahlani S; Burney IA; Al-Dhahli B; Al-Kharusi S; Al-Kharousi F; Al-Kalbani A; Ahmed I BMC Pharmacol Toxicol; 2020 Sep; 21(1):64. PubMed ID: 32867831 [TBL] [Abstract][Full Text] [Related]
14. 3-acetyl-11-keto-beta-boswellic acid decreases the malignancy of taxol resistant human ovarian cancer by inhibiting multidrug resistance (MDR) proteins function. Jin L; Yingchun W; Zhujun S; Yinan W; Dongchen W; Hui Y; Xi Y; Wanzhou Z; Buluan Z; Jinhua W Biomed Pharmacother; 2019 Aug; 116():108992. PubMed ID: 31129513 [TBL] [Abstract][Full Text] [Related]
15. Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesis. Pang X; Yi Z; Zhang X; Sung B; Qu W; Lian X; Aggarwal BB; Liu M Cancer Res; 2009 Jul; 69(14):5893-900. PubMed ID: 19567671 [TBL] [Abstract][Full Text] [Related]
16. [Chinese medicinal compound CFF-1 induces the apoptosis and cycle-arrest of prostate cancer cells via the PI3K/AKT/FOXO1 signaling pathway]. Zhang Y; Wu ZM; Lei BH; Lu ZJ; Zhu QY; Xu FS; Zhang MS; Liu P Zhonghua Nan Ke Xue; 2017 Sep; 23(9):828-837. PubMed ID: 29726666 [TBL] [Abstract][Full Text] [Related]
17. MiR-1/GOLPH3/Foxo1 Signaling Pathway Regulates Proliferation of Bladder Cancer. Liu MK; Ma T; Yu Y; Suo Y; Li K; Song SC; Zhang W Technol Cancer Res Treat; 2019; 18():1533033819886897. PubMed ID: 31714185 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of glioblastoma progression by Urolithin A in vitro and in vivo by regulating Sirt1-FOXO1 axis via ERK/AKT signaling pathways. Liu CL; Zhao D; Li JJ; Liu S; An JJ; Wang D; Hu FA; Qiu CY; Cui MH Neoplasma; 2022 Jan; 69(1):80-94. PubMed ID: 34818027 [TBL] [Abstract][Full Text] [Related]
19. Propofol inhibits proliferation and cisplatin resistance in ovarian cancer cells through regulating the microRNA‑374a/forkhead box O1 signaling axis. Sun Y; Peng YB; Ye LL; Ma LX; Zou MY; Cheng ZG Mol Med Rep; 2020 Mar; 21(3):1471-1480. PubMed ID: 32016462 [TBL] [Abstract][Full Text] [Related]
20. Cirsiliol induces autophagy and mitochondrial apoptosis through the AKT/FOXO1 axis and influences methotrexate resistance in osteosarcoma. Luo M; Su Z; Gao H; Tan J; Liao R; Yang J; Lin L J Transl Med; 2023 Dec; 21(1):907. PubMed ID: 38087310 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]